GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
EBITDA Growth
-76.45%
Quarterly · Period ending:
GSK EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-76.45%period ending
Latest reported-76.45%period ending
GSK Quarterly EBITDA YoY % (15.13% → -76.45%)
Year-over-year change
High-resolution chart · PNG
GSK ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -76.4457% | |
| -10.3136% | |
| 70.3919% | |
| 187.0196% | |
| 39.948% | |
| 49.4203% | |
| -3.2844% | |
| -54.1144% | |
| -12.0427% | |
| -24.7273% | |
| -37.4565% | |
| 17.7122% | |
| 30.0942% | |
| 1.2146% | |
| 54.4954% | |
| -5.5749% | |
| 11.8071% | |
| 30.625% | |
| -67.6818% | |
| -8.5259% | |
| -41.1227% | |
| -7.8831% | |
| 53.5323% | |
| -7.3459% | |
| 34.563% | |
| -16.4323% | |
| 7.5868% | |
| 11.2983% | |
| 127.0189% | |
| 54.6651% | |
| 429.0094% | |
| -5.9869% | |
| -8.901% | |
| -15.6039% | |
| -65.2744% | |
| 57.4818% | |
| 313.9098% | |
| 59.3533% | |
| 2,613.3333% | |
| 29.0424% | |
| -75.1634% | |
| -87.6297% | |
| -94.7121% | |
| 14.9819% | |
| -30.3641% | |
| 533.3534% | |
| -62.5605% | |
| -52.3236% | |
| -24.2738% | |
| -23.7% | |
| -11.8651% | |
| 19.0574% | |
| 3.2537% | |
| -5.192% | |
| 19.6197% | |
| -27.9439% | |
| -13.2716% | |
| -17.761% | |
| 4,327.451% | |
| 5.7377% | |
| 309.3863% | |
| 7.1099% | |
| -101.8365% | |
| -1.1955% | |
| -76.8588% | |
| 5.2589% | |
| 48.1067% | |
| 19.7138% | |
| 2.3952% | |
| 5.0127% | |
| -8.4804% | |
| 383.7475% | |
| 3.1319% | |
| -6.3271% | |
| 34.6767% | |
| -81.3901% | |
| 0.1298% | |
| 4.5691% | |
| 131.343% | |
| 13.5441% | |
| 14.5464% | |
| 26.0197% | |
| -592.1521% | |
| 16.6393% | |
| -0.6262% | |
| 4.7802% | |
| -17.7144% | |
| -12.532% | |
| -5.4856% | |
| -2.285% | |
| -26.0198% | |
| 50.2894% | |
| 15.5651% | |
| 8.7308% | |
| -48.0939% | |
| 47.0213% | |
| 10.6318% | |
| 41.6873% | |
| 13.906% | |
| -16.2956% |